Anti-SYNDIG1 monoclonal antibody

Pre-made anti-SYNDIG1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYNDIG1/SYNDIG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1863-Ab-1/ GM-Tg-hg-IP1863-Ab-2Anti-Human SYNDIG1 monoclonal antibodyHuman
GM-Tg-rg-IP1863-Ab-1/ GM-Tg-rg-IP1863-Ab-2Anti-Rat SYNDIG1 monoclonal antibodyRat
GM-Tg-mg-IP1863-Ab-1/ GM-Tg-mg-IP1863-Ab-2Anti-Mouse SYNDIG1 monoclonal antibodyMouse
GM-Tg-cynog-IP1863-Ab-1/ GM-Tg-cynog-IP1863-Ab-2Anti-Cynomolgus/ Rhesus macaque SYNDIG1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1863-Ab-1/ GM-Tg-felg-IP1863-Ab-2Anti-Feline SYNDIG1 monoclonal antibodyFeline
GM-Tg-cang-IP1863-Ab-1/ GM-Tg-cang-IP1863-Ab-2Anti-Canine SYNDIG1 monoclonal antibodyCanine
GM-Tg-bovg-IP1863-Ab-1/ GM-Tg-bovg-IP1863-Ab-2Anti-Bovine SYNDIG1 monoclonal antibodyBovine
GM-Tg-equg-IP1863-Ab-1/ GM-Tg-equg-IP1863-Ab-2Anti-Equine SYNDIG1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1863-Ab-1/ GM-Tg-hg-IP1863-Ab-2; GM-Tg-rg-IP1863-Ab-1/ GM-Tg-rg-IP1863-Ab-2;
GM-Tg-mg-IP1863-Ab-1/ GM-Tg-mg-IP1863-Ab-2; GM-Tg-cynog-IP1863-Ab-1/ GM-Tg-cynog-IP1863-Ab-2;
GM-Tg-felg-IP1863-Ab-1/ GM-Tg-felg-IP1863-Ab-2; GM-Tg-cang-IP1863-Ab-1/ GM-Tg-cang-IP1863-Ab-2;
GM-Tg-bovg-IP1863-Ab-1/ GM-Tg-bovg-IP1863-Ab-2; GM-Tg-equg-IP1863-Ab-1/ GM-Tg-equg-IP1863-Ab-2
Products NameAnti-SYNDIG1 monoclonal antibody
Formatmab
Target NameSYNDIG1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYNDIG1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1863-Ag-1Recombinant multi-species SYNG1/ SYNDIG1/ C20orf39 protein


    Target information

    Target IDGM-IP1863
    Target NameSYNDIG1
    Gene ID79953,433485,362235,704737,612795,101088829,541217,100049829
    Gene Symbol and SynonymsC20orf39,DSPC2,Gm14134,H2C20orf39,IFI™D5,RGD1310753,SYNDIG1,™EM90B
    Uniprot AccessionQ9H7V2,Q58DZ9,Q08DM6
    Uniprot Entry NameSYNG1_HUMAN,SYNG1_RAT,SYNG1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101463
    Target ClassificationN/A

    The target: SYNDIG1, gene name: SYNDIG1, also named as C20orf39, DSPC2, IFI™D5, ™EM90B. This gene encodes a protein that belongs to the interferon-induced transmembrane family of proteins. A similar protein in rat is thought to regulate the development of excitatory synapses. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.